News

Pacira BioSciences Announces Participation in Key Healthcare Events

Pacira BioSciences Announces Participation in Key Healthcare Events

Pacira BioSciences to Engage in Upcoming Healthcare Conferences

Pacira BioSciences, Inc. (Nasdaq: PCRX), recognized for its dedication to innovative, non-opioid pain management solutions, has exciting news for the healthcare community. The company will actively participate in two significant conferences in the near future, showcasing their commitment to enhancing patient care and treatment options.

Details on Conference Participation

Pacira will be featured in an analyst-led fireside chat at the following healthcare conferences:

RBC Capital Markets Global Healthcare Conference

This conference is set to take place on a Wednesday at 8:30 AM ET. The RBC Capital Markets Global Healthcare Conference presents a vital opportunity for Pacira to discuss ongoing developments in non-opioid pain management.

Jefferies Global Healthcare Conference

Following closely, Pacira will also be part of the Jefferies Global Healthcare Conference on a Wednesday at 8:45 AM ET. This event will further allow the company to interact with analysts and showcase their innovative treatments.

Access to Live Audio and Webcast

For those interested in tuning in, live audio of the virtual events will be available. Interested parties can find more information on the company’s official events page. Additionally, a replay of these sessions will be accessible for two weeks post-event, ensuring that those unable to attend live can still benefit from the insights shared.

About Pacira BioSciences

At the heart of Pacira's operations is a focus on delivering non-opioid therapies that significantly improve the quality of life for patients facing pain. They offer a diverse range of commercial-stage treatments:

EXPAREL

EXPAREL (bupivacaine liposome injectable suspension) is a long-lasting local pain relief option approved for various forms of surgical pain management, including infiltration and nerve blocks.

ZILRETTA

ZILRETTA (triamcinolone acetonide extended-release injectable suspension) is useful for managing osteoarthritis pain in the knee, providing extended relief to patients.

iOVERA

Introducing the ioveraº device, this handheld solution offers immediate, drug-free pain relief targeting nerves through controlled cold therapy, underscoring Pacira's innovative approach to pain management.

Looking to the future, Pacira is advancing the potential of PCRX-201 (enekinragene inzadenovec), a groundbreaking gene therapy aimed at treating widespread conditions like osteoarthritis. This exciting development could represent a remarkable leap forward in therapeutic options.

For more information about Pacira BioSciences and their commitment to non-opioid solutions, visit their official website.

Frequently Asked Questions

What is the focus of Pacira BioSciences?

Pacira BioSciences focuses on delivering innovative non-opioid therapies to improve patient quality of life and pain management.

When will Pacira participate in the upcoming conferences?

Pacira will participate in the RBC Capital Markets Global Healthcare Conference and the Jefferies Global Healthcare Conference on specified dates at respective times.

How can I access the live audio of the events?

Live audio can be accessed through the Events page on the Pacira BioSciences website.

What treatments does Pacira currently offer?

Pacira offers treatments such as EXPAREL for surgical pain management, ZILRETTA for osteoarthritis knee pain, and the ioveraº device for cold therapy pain relief.

What is the significance of PCRX-201?

PCRX-201 is an innovative gene therapy under development aimed at treating large-scale diseases, like osteoarthritis, representing a significant advancement in treatment options.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ON1 Photo RAW 2027: New AI Tools, Better Processing

Updated Category News Views 0

Aiming for the Photography Crown ON1 isn't just tinkering on the fringes with their new Photo RAW 2027 release—they're diving headfirst into the deep end, aiming to outdo giants in the RAW processing world. I've seen my share of software updates that don't move the needle, but this one's packed to the gills with updates that photographers have been clamoring for. What's...

Continue Reading
Clarivate Integrates Trademark Data with Microsoft AI

Updated Category News Views 8

You know, the market's all abuzz with AI this, AI that. But today, we're getting a glimpse at something that isn't just hyped-up vaporware; it's actually useful. Clarivate Plc (NYSE:CLVT), which has carved a niche in transformative intelligence, is teaming up with Microsoft to slide their CompuMark trademark data into Microsoft Copilot via something they call IPOne. It's...

Continue Reading
New Leadership Fuels Expansion of Black Optix Tint

Updated Category News Views 53

Shifting Gears with New Leadership Black Optix Tint isn't just revamping its car-styling game; it's refueling the entire brand with the appointment of Jeff Stark as its new brand president. This guy's entry into the picture is like putting nitro in the tank of a franchise that's already got some serious road miles behind it. With over 15 years under his belt in the...

Continue Reading
Cleafy's Cyber-Fraud Edge in SPARK Matrix™ 2026

Updated Category News Views 58

What's Cookin'? Cleafy Leads in Fraud Management Lineup Eying the world through a prism of calculated risk and opportunity, Cleafy has emerged a big dog in the latest QKS Group SPARK Matrix™ for Enterprise Fraud Management, 2026. The spotlight's on their cutting-edge knack for dodging cyber fraud's punches, a distinction that hints at a deeper market shift for those who...

Continue Reading
3W Auto-life Unveils New Products at SEMA Show 2026

Updated Category News Views 15

Revving Up Interest at SEMA with 3W Auto-life If there's ever a mecca for car accessories in the automotive world, the SEMA Show in Las Vegas is it. Right there in the West Hall, Booth #54169, 3W Auto-life is flaunting their 2026 lineup, marking a decade of transformation in vehicle interior protection. From upgraded floor mats for the Tesla Model Y Juniper and the Toyota...

Continue Reading
AAR's Big Bet on Notes Amid MRO Holdings Acquisition

Updated Category News Views 9

AAR's $1.9 Billion Move in the Aviation Arena The aviation aftermarket giant AAR isn't just dipping its toes into the bond market—it's diving in headfirst with a hefty $1.9 billion in senior notes. These notes, spread across two separate issues due in 2031 and 2034, are part of a broader strategy to finance the takeover of MRO Holdings. It's a bold move, but in the...

Continue Reading
Ceva and Mobilint's New REGULUS: A Game Changer?

Updated Category News Views 71

A Big Leap for Physical AI Can't pretend I saw this coming—Ceva's making waves with Mobilint's new REGULUS edge AI SoC, aiming to flip the script on how we think about physical AI devices. This combo of Ceva's NeuPro NPU and SensPro AI DSP is more than just tech talk; it's a gutsy move that shows us edge devices might be the hunting ground for AI innovation. Sensors and...

Continue Reading
ENGWE Unleashes Massive Black Friday E-Bike Discounts

Updated Category News Views 93

ENGWE Powers Up the 2026 Black Friday Storm If you’ve ever been on the hunt for a reliable e-bike, ENGWE is making a racket that’ll be impossible to ignore this Black Friday. Starting November 2nd and running up to December 3rd, they’re throwing down the gauntlet with some jaw-dropping deals across their line-up. Now, why should you care? For starters, they’ve...

Continue Reading
Curaleaf Takes Stake in NJ's Boone Town Dispensary

Updated Category News Views 109

Curaleaf's Bold Move in the Garden State Curaleaf Holdings, Inc. is doubling down on its cannabis bet in New Jersey. The acquisition of an equity stake in Boone Town Provisions, located at 677 Myrtle Ave., Boonton, NJ, boosts Curaleaf’s dispensary count to four in the state. The company's not just wandering on the map; it's pinpointing high-performing locations to...

Continue Reading
November Oil Outlook: OPEC+ Steady, Key Earnings Ahead

Updated Category News Views 57

Oil's November Gambit: OPEC+ and U.S. Dynamics November's here, and boy, it's shaping up to be a wild one for the oil market. OPEC+ decided to stick with their oil production targets for December, leaving the supply faucets unchanged. This group, including big players like Saudi Arabia and Russia, met virtually and chose to hit the brakes on any changes just yet. With the...

Continue Reading

Top 5 Most Recently Viewed Articles

Alpine Banks of Colorado Secures Shareholder Approval for Stock Split

Updated Category News Views 282

Shareholder Approval for Stock Split and Articles Amendment Alpine Banks of Colorado (OTCQX: ALPIB) recently reached a significant milestone as it secured shareholder approval for critical adjustments to its corporate structure. These changes, voted on during the annual meeting, include the amendment and restatement of the Articles of Incorporation, which set the...

Continue Reading
John Drosos Joins Blue Ridge Partners as Managing Director

Updated Category News Views 65

Blue Ridge Partners Welcomes John Drosos as Managing Director Global management consultancy adds highly experienced and talented Managing Director to its growing leadership team. Expertise and Experience Blue Ridge Partners is excited to announce that John Drosos has joined the firm as Managing Director, bringing with him over 25 years of expertise in consulting, private...

Continue Reading
America's Economic Boom and the Path to a Better Future

Updated Category News Views 461

America's Economic Boom: An Update In a remarkable turn of events, America's economy is showcasing impressive growth and significant progress. Under the leadership of President Trump, the nation has become a focal point of economic success. With a clear emphasis on addressing fundamental issues, the current administration is working tirelessly to rectify longstanding...

Continue Reading
Effortless Home Selling: Explore a New 3-Step Process in Texas

Updated Category News Views 108

Simplified Home Selling in Texas Company That Buys Houses proudly introduces a revolutionary 3-step approach for homeowners looking to sell their property efficiently in Texas. This method is designed to provide an uncomplicated experience for those wanting to sell their homes in 'as-is' condition without the usual hassles of traditional real estate transactions....

Continue Reading
Projected Growth of Air Purifying Escape Respirators

Updated Category News Views 153

The Promising Future of the Air Purifying Escape Respirator Market The global Air Purifying Escape Respirator market is undergoing a transformation, with exciting growth projected over the next decade. Currently valued at approximately US$ 7.4 billion, it is anticipated to reach around US$ 12.9 billion, exhibiting a steady compound annual growth rate (CAGR) of 5.2%...

Continue Reading